Erasca Foundation proposes $151K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Erasca, Inc. (ERAS) is the issuer; Erasca Foundation, identified as a foundation, reports a proposed sale of 8,333 common shares with an aggregate market value of $150,843.19. The approximate sale date is April 15, 2026, and Merrill Lynch is listed as broker.
During the preceding three months, Erasca Foundation reported sales of 8,333 common shares on January 15, 2026, for gross proceeds of $68,573.87; on February 17, 2026, for $99,245.03; and on March 16, 2026, for $116,855.46. Its acquisition history lists 10,193,557 common shares acquired from Erasca, Inc. by donation on July 20, 2021.
Key Figures
Key Terms
Aggregate Market Value financial
Gross Proceeds financial
Nature of Acquisition Transaction financial
Approximate Date of Sale financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.